Fintel reports that on August 8, 2025, Stifel downgraded their outlook for Crocs (NasdaqGS:CROX) from Buy to Hold. Analyst ...

Fintel reports that on August 7, 2025, Stifel upgraded their outlook for ESAB (NYSE:ESAB) from Hold to Buy. Analyst Price ...

Members of the team at Stifel posed with the Siouxland Chamber of Commerce and many others, on July 31, 2025, for a ribbon ...

Alcon Inc. (NYSE:ALC) ranks among the best medical stocks to buy according to analysts. On July 10, Stifel reaffirmed its Buy ...

Thermo Fisher Scientific Inc. (NYSE:TMO) ranks among the best medical stocks to buy according to analysts. On July 25, Stifel ...

In the latest quarter, 4 analysts provided ratings for Stifel Financial SF, showcasing a mix of bullish and bearish perspectives. Summarizing their recent assessments, the table below illustrates ...

Stifel Financial recruited an advisor team that oversaw $2.1 billion in client assets at Oppenheimer & Co., making another big hire for Stifel this year. The team, called the Summa Group, joined ...

Stifel’s initiation of coverage on NewAmsterdam with a Buy rating and a $44 price target reflects their confidence in the company’s potential to outperform within the pharmaceutical industry ...

On Thursday, Stifel analysts reiterated their Buy rating and maintained a $1,050 price target for Equinix stock (NASDAQ: EQIX), above the current price of $912.20. The decision followed ...

Stifel Financial completes acquisition of Bryan Garnier, enhancing European capabilities in technology and healthcare investment banking.

ST. LOUIS, June 02, 2025 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today announced the completion of its acquisition of Bryan, Garnier & Co. (“Bryan Garnier”), a leading ...

Stifel recommends “defensive value” stocks for the remainder of 2025, and the firm has these five rated Buy.